Central Nervous System Agents in Medicinal Chemistry
Title:Editorial: Neurodegenerative Disorders: Synthesis, Drug Delivery Strategies and Biological Evaluation of New Therapeutic Agents
Volume: 17 Issue: 2
Author(s): Antonio Di Stefano*Marcella Reale*
Affiliation:
- Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, Chieti Scalo (CH),Italy
- Department of Medical and Oral Sciences and Biotechnologies, School of Medicine and Health Sciences, University "G.d'Annunzio" Chieti-Pescara, Chieti,Italy
Export Options
About this article
Cite this article as:
Di Stefano Antonio*, Reale Marcella*, Editorial: Neurodegenerative Disorders: Synthesis, Drug Delivery Strategies and Biological Evaluation of New Therapeutic Agents, Central Nervous System Agents in Medicinal Chemistry 2017; 17 (2) . https://dx.doi.org/10.2174/187152491702170712214058
DOI https://dx.doi.org/10.2174/187152491702170712214058 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B))
Current Pharmaceutical Design Functional Switch From Pro-Neurotrophins to Mature Neurotrophins
Current Protein & Peptide Science Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Current Topics in Medicinal Chemistry Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology Retinal Degenerations: From Cell Signaling to Cell Therapy; Pre-Clinical and Clinical Issues
Current Gene Therapy Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target
CNS & Neurological Disorders - Drug Targets Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Modulation of γ<sub>2</sub>-MSH Hepatoprotection by Antisense Peptides and Melanocortin Subtype 3 and 4 Receptor Antagonists
Medicinal Chemistry Brain Oxidative Stress - Analytical Chemistry and Thermodynamics of Glutathione and NADPH
Current Topics in Medicinal Chemistry Autophagy in Diabetic Retinopathy
Current Neuropharmacology Investigational Selective Melatoninergic Ligands for Receptor Subtype MT2
Mini-Reviews in Medicinal Chemistry Latest Progress in the Identification of Novel Synthetic Ligands for the Cannabinoid CB2 Receptor
Mini-Reviews in Medicinal Chemistry Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Localisation of Endothelin-1 and its Receptors in Vascular Tissue as Seen at the Electron Microscopic Level
Current Vascular Pharmacology Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology Ketamine: New Indications for an Old Drug
Current Drug Targets The Concomitance of Hypertension and Diabetes Exacerbating Retinopathy: The Role of Inflammation and Oxidative Stress.
Current Clinical Pharmacology Regulation of Neuronal Cell Death and Neurodegeneration by Members of the Bcl-2 Family: Therapeutic Implications
Current Drug Targets - CNS & Neurological Disorders Patent Selections
Recent Patents on Food, Nutrition & Agriculture Tryptophan Catabolites and Migraine
Current Pharmaceutical Design